UPDATE : Monday, December 9, 2019
상단여백
Doctor fuels controversy with YouTube advice on how to take dog dewormer
Recently, several cancer patients were admitted to university hospitals due...
by Lee Hye-seon  |  2019-11-18 16:47
라인
KDA, KBR team up for global promotion of Korean medicine
Korean Diabetes Association (KDA), Korea’s first healthcare-focused English...
by Lee Hye-seon  |  2019-11-08 14:09
라인
Regulator allows easier access to clinical trial participation, inquiry
The regulator said it would allow patients and guardians to check with info...
by Lee Hye-seon  |  2019-10-24 15:36
라인
Drug regulator to hire 87 more reviewers next year
The Ministry of Food and Drug Safety said it would add 87 staff for the rev...
by Lee Hye-seon  |  2019-10-11 16:35
라인
Allergan Korea to replace breast implant without time limit
Allergan Korea CEO Kim Ji-hyun said she would lift the two-year time limit ...
by Lee Hye-seon  |  2019-10-08 15:22
라인
Civic group protests regulator’s inaction over insulin pumps FDA recalled
A civic group supporting diabetic patients said it would hold a rally to pr...
by Lee Hye-seon  |  2019-10-07 16:10
라인
‘New law to support advanced biopharmaceuticals, ensure safety’
The Ministry of Food and Drug Safety is preparing to implement the “Act on ...
by Lee Hye-seon  |  2019-10-04 15:18
라인
Authorities to test drugs of ranitidine family for carcinogen risk
The Ministry of Food and Drug Safety said it might test all stomach medicin...
by Lee Hye-seon  |  2019-10-02 14:51
라인
Allergan to compensate breast implant recipients for damage
Allergan agreed to provide full compensation for the medical expenses of pa...
by Lee Hye-seon  |  2019-09-30 15:33
라인
Sale of Novartis’ conjunctivitis drug Pataday banned for 3 months
The Ministry of Food and Drug Safety has suspended the sale of Novartis Kor...
by Lee Hye-seon  |  2019-09-30 11:25
라인
Ranitidine heartburn drugs banned due to carcinogen risk
The Ministry of Food and Drug Safety has suspended the manufacturing and se...
by Lee Hye-seon  |  2019-09-26 13:32
라인
Ministry to announce results of ranitidine testing for carcinogen
The government is likely to announce the results of the test on ranitidine ...
by Lee Hye-seon  |  2019-09-25 14:46
라인
Indian biosimilar of rituximab to undergo test in Korea
India’s largest generics drugmaker Dr. Reddy's Laboratories said it wou...
by Lee Hye-seon  |  2019-09-19 10:31
라인
Regulator inspects heartburn drugs after US finds carcinogen
After U.S. health officials said they detected low levels of a potentially ...
by Lee Hye-seon  |  2019-09-16 14:01
라인
Lilly’s migraine treatment Emgality lands in Korea
Lilly’s new migraine treatment Emgality Prefilled Pen Inj. (ingredient: gal...
by Lee Hye-seon  |  2019-09-05 16:24
라인
Multiple myeloma treatment isatuximab named orphan drug
The drug regulator designated isatuximab, a treatment for relapsed and refr...
by Lee Hye-seon  |  2019-09-03 11:21
라인
SK Biopharmaceutical’s sleepiness drug initially aimed to treat depression
Sunosi (ingredient: solriamfetol), a treatment for narcolepsy developed by ...
by Lee Hye-seon  |  2019-08-22 15:37
라인
‘Ministry to provide quick measures for users of Allergan’s breast implants’
Fear is spreading among Korean women who received Allergan’s specific breas...
by Lee Hye-seon  |  2019-08-21 15:20
라인
Combo drugs: latest trend in local pharmaceuticals
Domestic pharmaceutical companies are actively developing combination drugs...
by Lee Hye-seon  |  2019-08-19 16:02
라인
Rare cancer reported in Korea regarding Allergan’s breast implant
The health authorities said here they have received the first report of bre...
by Lee Hye-seon  |  2019-08-16 14:54
여백
여백
여백
Back to Top